XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -2.09%4.34B | -2.09%4.34B | 27.60%3.53B | -3.50%2.71B | -5.26%3.17B | 2.06%4.43B | 2.06%4.43B | -15.90%2.77B | -15.49%2.81B | -16.66%3.35B |
-Cash and cash equivalents | -2.09%4.34B | -2.09%4.34B | 27.60%3.53B | -0.82%2.71B | -2.72%3.17B | 3.51%4.43B | 3.51%4.43B | -13.41%2.77B | -14.70%2.73B | -16.92%3.26B |
-Short-term investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | -36.70%75.9M | -5.72%87.4M |
Receivables | 6.72%9.24B | 6.72%9.24B | 17.64%8.57B | 13.03%8.43B | 11.95%7.91B | 6.95%8.66B | 6.95%8.66B | 11.52%7.29B | 5.91%7.46B | -0.13%7.06B |
-Accounts receivable | 6.72%9.24B | 6.72%9.24B | 17.64%8.57B | 13.03%8.43B | 11.95%7.91B | 6.95%8.66B | 6.95%8.66B | 11.52%7.29B | 5.91%7.46B | -0.13%7.06B |
Inventory | 20.83%1.62B | 20.83%1.62B | 17.37%1.9B | 9.89%1.8B | 13.43%1.71B | 7.01%1.34B | 7.01%1.34B | 18.71%1.62B | 32.53%1.64B | 14.59%1.51B |
Other current assets | 7.32%1.02B | 7.32%1.02B | 24.04%1.11B | 13.70%1.03B | 10.35%1.08B | 3.38%949.9M | 3.38%949.9M | 6.03%892.6M | 1.40%904.3M | -1.58%975.2M |
Total current assets | 5.45%16.22B | 5.45%16.22B | 20.25%15.11B | 9.05%13.97B | 7.53%13.87B | 5.28%15.38B | 5.28%15.38B | 4.44%12.56B | 2.53%12.81B | -3.75%12.9B |
Non current assets | ||||||||||
Net PPE | -2.76%1.87B | -2.76%1.87B | 0.50%1.91B | -4.13%1.88B | -4.07%1.88B | -6.96%1.92B | -6.96%1.92B | -5.66%1.9B | -6.52%1.96B | -9.83%1.96B |
-Gross PPE | -3.47%2.97B | -3.47%2.97B | 1.08%3.06B | -2.60%3.01B | -3.88%3.04B | -4.98%3.07B | -4.98%3.07B | -3.94%3.03B | -5.16%3.09B | -5.56%3.17B |
-Accumulated depreciation | 4.65%-1.1B | 4.65%-1.1B | -2.05%-1.15B | -0.04%-1.13B | 3.57%-1.16B | 1.46%-1.15B | 1.46%-1.15B | 0.89%-1.13B | 2.71%-1.13B | -2.33%-1.21B |
Goodwill and other intangible assets | 7.18%11.2B | 7.18%11.2B | 11.61%11.47B | 11.78%11.17B | 11.23%11.23B | 4.00%10.45B | 4.00%10.45B | 4.64%10.27B | -0.41%9.99B | -1.87%10.09B |
-Goodwill | 5.90%10.68B | 5.90%10.68B | 10.50%10.93B | 9.72%10.65B | 9.20%10.69B | 3.57%10.08B | 3.57%10.08B | 4.10%9.89B | 0.02%9.7B | -1.60%9.79B |
-Other intangible assets | 42.27%522M | 42.27%522M | 40.14%539.4M | 80.87%522.7M | 77.49%533M | 17.07%366.9M | 17.07%366.9M | 20.73%384.9M | -12.82%289M | -9.82%300.3M |
Investments and advances | -11.14%59M | -11.14%59M | 0.61%65.8M | -5.66%63.3M | -2.41%64.8M | 0.30%66.4M | 0.30%66.4M | 1.87%65.4M | -3.59%67.1M | -14.43%66.4M |
Other non current assets | 21.25%271M | 21.25%271M | 19.13%241.6M | 1.79%243.9M | 6.53%236.4M | 6.18%223.5M | 6.18%223.5M | 0.15%202.8M | 12.17%239.6M | 5.27%221.9M |
Total non current assets | 5.82%13.4B | 5.82%13.4B | 9.98%13.69B | 8.95%13.35B | 8.64%13.41B | 2.19%12.66B | 2.19%12.66B | 2.84%12.45B | -1.24%12.26B | -3.18%12.34B |
Total assets | 5.62%29.62B | 5.62%29.62B | 15.14%28.8B | 9.00%27.32B | 8.08%27.28B | 3.86%28.04B | 3.86%28.04B | 3.64%25.01B | 0.65%25.07B | -3.47%25.24B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 7.52%12.89B | 7.52%12.89B | 14.07%11.21B | 7.55%10.89B | 8.06%10.72B | 6.07%11.99B | 6.07%11.99B | 6.28%9.83B | 4.22%10.12B | -3.02%9.92B |
-accounts payable | 7.31%12.48B | 7.31%12.48B | 13.92%10.94B | 7.03%10.65B | 7.85%10.34B | 5.76%11.63B | 5.76%11.63B | 6.35%9.6B | 4.14%9.95B | -3.18%9.59B |
-Total tax payable | 14.48%402.5M | 14.48%402.5M | 20.34%270.4M | 37.54%241.1M | 14.00%381M | 17.20%351.6M | 17.20%351.6M | 3.31%224.7M | 9.15%175.3M | 1.74%334.2M |
Current debt and capital lease obligation | -97.20%21.3M | -97.20%21.3M | 5,188.97%766.9M | 3,633.17%765.3M | 4,016.22%761.5M | 4,405.33%761.4M | 4,405.33%761.4M | 42.16%14.5M | 66.67%20.5M | 49.19%18.5M |
-Current debt | -97.20%21.3M | -97.20%21.3M | 5,188.97%766.9M | 3,633.17%765.3M | 4,016.22%761.5M | 4,405.33%761.4M | 4,405.33%761.4M | 42.16%14.5M | 66.67%20.5M | 49.19%18.5M |
Current deferred liabilities | -1.48%1.34B | -1.48%1.34B | 9.25%1.3B | 8.83%1.26B | -3.24%1.24B | -9.12%1.36B | -9.12%1.36B | -12.21%1.19B | -15.52%1.16B | -12.58%1.28B |
Other current liabilities | -4.05%2.06B | -4.05%2.06B | 5.13%2.09B | 2.20%2.04B | -0.54%2.24B | -4.48%2.14B | -4.48%2.14B | -5.04%1.99B | -5.57%2B | -9.11%2.25B |
Current liabilities | 0.33%16.3B | 0.33%16.3B | 18.03%15.37B | 12.45%14.96B | 11.06%14.95B | 7.93%16.25B | 7.93%16.25B | 2.47%13.02B | 0.66%13.3B | -5.02%13.47B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 19.29%6.85B | 19.29%6.85B | 9.32%7B | -2.60%6.3B | -2.64%6.33B | -11.35%5.74B | -11.35%5.74B | 0.51%6.4B | -0.36%6.46B | -1.46%6.5B |
-Long term debt | 23.44%6.04B | 23.44%6.04B | 10.91%6.18B | -2.21%5.49B | -1.93%5.5B | -12.34%4.89B | -12.34%4.89B | 2.23%5.57B | 1.18%5.61B | -0.66%5.61B |
-Long term capital lease obligation | -4.55%814.2M | -4.55%814.2M | -1.35%816.8M | -5.16%806.2M | -7.13%827.2M | -5.22%853M | -5.22%853M | -9.73%828M | -9.41%850.1M | -6.25%890.7M |
Non current deferred liabilities | -7.05%491.8M | -7.05%491.8M | 5.20%558.5M | 5.33%533.8M | 17.11%514.8M | 11.23%529.1M | 11.23%529.1M | 5.69%530.9M | -0.20%506.8M | -4.04%439.6M |
Other non current liabilities | -9.41%804.2M | -9.41%804.2M | -3.60%874.2M | 9.18%881M | 9.08%916.2M | 5.99%887.7M | 5.99%887.7M | -0.77%906.8M | -13.53%806.9M | -12.51%839.9M |
Total non current liabilities | 13.78%8.15B | 13.78%8.15B | 7.55%8.43B | -0.86%7.71B | -0.26%7.76B | -8.11%7.16B | -8.11%7.16B | 0.69%7.84B | -1.90%7.78B | -2.93%7.78B |
Total liabilities | 4.45%24.45B | 4.45%24.45B | 14.09%23.8B | 7.54%22.67B | 6.91%22.71B | 2.46%23.4B | 2.46%23.4B | 1.79%20.86B | -0.30%21.08B | -4.27%21.24B |
Shareholders'equity | ||||||||||
Share capital | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M |
-common stock | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M | 0.00%44.6M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 8.79%11.5B | 8.79%11.5B | 8.81%11.19B | 8.85%10.94B | 9.42%10.75B | 8.54%10.57B | 8.54%10.57B | 8.81%10.28B | 8.89%10.05B | 8.84%9.83B |
Paid-in capital | -4.04%472.1M | -4.04%472.1M | -19.02%415.2M | -20.04%468.4M | -11.83%512M | -13.85%492M | -13.85%492M | -7.14%512.7M | 3.32%585.8M | -0.65%580.7M |
Less: Treasury stock | 3.15%6.35B | 3.15%6.35B | 4.38%6.42B | 3.22%6.37B | 6.27%6.32B | 8.64%6.15B | 8.64%6.15B | 10.55%6.15B | 11.84%6.17B | 9.49%5.95B |
Gains losses not affecting retained earnings | -10.34%-1.48B | -10.34%-1.48B | 12.63%-1.27B | -6.74%-1.45B | -2.27%-1.42B | 6.98%-1.34B | 6.98%-1.34B | 15.91%-1.46B | 9.03%-1.35B | -13.24%-1.38B |
Total stockholders'equity | 15.96%4.19B | 15.96%4.19B | 22.38%3.95B | 15.29%3.64B | 14.53%3.57B | 11.20%3.62B | 11.20%3.62B | 17.55%3.23B | 11.31%3.15B | 3.90%3.12B |
Noncontrolling interests | -4.10%981.4M | -4.10%981.4M | 13.49%1.05B | 22.20%1.02B | 13.33%993.1M | 12.81%1.02B | 12.81%1.02B | 3.24%925.2M | -10.24%835.4M | -8.16%876.3M |
Total equity | 11.54%5.17B | 11.54%5.17B | 20.40%5B | 16.74%4.66B | 14.27%4.56B | 11.55%4.64B | 11.55%4.64B | 14.03%4.15B | 5.98%3.99B | 0.99%3.99B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |